Proportion of Companies with Pre-increased Interim Reports Rises, Emerging Industries Boost Performance Growth 中报预增公司占比走高，新兴产业助力业绩增长

Summary

The proportion of A-share companies forecasting increased profits in their interim reports reaches 88.89%, with emerging industries such as biomedicine, chemicals, and semiconductors showing outstanding performance.
Some listed companies have explicitly attributed their profit growth to AI-enabled business transformation and improved operational efficiency.
Institutional investors’ intensive research focuses on future growth drivers and H2 outlooks, reflecting market confidence.

Deep Analysis

TL;DR

• The proportion of A-share companies forecasting increased profits in their interim reports reaches 88.89%, with emerging industries such as biomedicine, chemicals, and semiconductors showing outstanding performance.
• Some listed companies have explicitly attributed their profit growth to AI-enabled business transformation and improved operational efficiency.
• Institutional investors’ intensive research focuses on future growth drivers and H2 outlooks, reflecting market confidence.

Why It’s Worth Reading

This article reveals early signs of AI technology transitioning from proof-of-concept to actual commercial value, particularly in traditional manufacturing and pharmaceutical sectors. For investors, identifying “AI+” stocks with realized earnings is more strategically significant than merely chasing concepts; for practitioners, it provides industry case studies demonstrating tangible financial returns from AI implementation.

Technical Analysis

• Data Support: Based on Wind data, as of July 6, 64 out of 72 companies that disclosed interim report forecasts predicted profit increases, resulting in an increase rate of approximately 88.89%.
• Benefiting Industries: Biomedicine, chemicals, and semiconductors were the primary sectors with significant profit forecast increases, indicating that these capital-intensive and technology-intensive fields responded most rapidly to AI integration.
• Implementation Scenarios: While specific algorithmic models are not mentioned, the text indicates that AI primarily drives performance through “enabling business transformation” and “improving operational efficiency,” suggesting applications focus on non-generative core areas such as process optimization, predictive maintenance, or accelerated R&D.

Industry Insights

• AI Commercialization Enters Deep Water: Companies are no longer valued solely on AI narratives but are beginning to substantively reduce costs, improve efficiency, and reflect these gains in financial report profits. Focus should be placed on companies with concrete cost-reduction and efficiency-improvement cases.
• Enhanced Industrial Synergy: The integration of AI with traditional industries (e.g., chemicals, pharmaceuticals) is forming new growth poles, making cross-sectoral convergence a key path to enhancing competitiveness.
• Capital Market Barometer: The high attention paid by institutions to “AI-enabled performance” indicates that market logic has shifted from thematic speculation to fundamental verification. Enterprises with genuine AI implementation results will command higher premiums.

TL;DR

• A股中报预增比例高达88.89%，生物医药、化工、半导体等新兴产业表现突出。
• 部分上市公司明确将业绩增长归因于AI赋能业务转型及运营效率提升。
• 机构密集调研关注点集中在业绩未来增长点及下半年展望，反映市场信心。

为什么值得看

本文揭示了AI技术从概念验证向实际商业价值转化的早期迹象，特别是在传统制造业和医药领域的应用成效。对于投资者而言，识别“AI+”业绩兑现标的比单纯追逐概念更具战略意义；对于从业者，这提供了AI落地产生真金白银回报的行业案例参考。

技术解析

• 数据支撑：基于Wind数据，截至7月6日，72家披露中报预告的公司中64家预增，预增率约88.89%。
• 受益行业：生物医药、化工、半导体是大幅预增的主要行业，显示这些资本密集型和技术密集型领域对AI改造响应最快。
• 落地场景：文中未提及具体算法模型，但指出AI主要通过“赋能业务转型”和“提升运营效率”来驱动业绩，暗示应用集中在流程优化、预测性维护或研发加速等非生成式核心环节。

行业启示

• AI商业化进入深水区：企业不再仅靠AI故事估值，而是开始通过AI实质性降低成本、提高效率并体现在财报利润中，需重点关注有实际降本增效案例的公司。
• 产业协同效应增强：AI与传统行业（如化工、医药）的结合正在形成新的增长极，跨界融合成为提升竞争力的关键路径。
• 资本市场风向标：机构对“AI赋能业绩”的高度关注表明，市场逻辑已从题材炒作转向基本面验证，具备真实AI落地成果的企业将获得更高溢价。